Back to NewsPublished: 8 Jan 2026Download AppJoin TelegramPanacea Bio’s Dengue Vaccine Trial Completes Enrollment, Shares Rise 6%#Panacea Bio#Dengue Vaccine#Stock Market#Phase III TrialDownload AppJoin CommunityShare Article